AstraZeneca has launched a separate business unit that will take what the drugmaker has learned from running digitally-powered clinical trials and offer that experience to other sponsors.

阿斯利康已经启动了一个独立的业务部门，将把药品制造商从运行数字动力临床试验中学到的东西，并向其他赞助商提供这种经验。

Called Evinova, the new unit has emerged with alliances already in place with contract research organisations Parexel and Fortrea, which will help to promote its digital health products and services to their customers.

这个名为Evinova的新部门已经与合同研究组织Parexel和Fortrea建立了联盟，这将有助于向客户推广其数字健康产品和服务。

The business revolves around the Evinova drug development suite, a digital suite that covers the design and planning of new clinical trials, drawing on artificial intelligence and machine learning, and the collection of study data in a number of ways including through the use of connected medical devices and wearable sensors..

该业务围绕着Evinova药物开发套件，这是一个数字套件，涵盖新临床试验的设计和规划，利用人工智能和机器学习，以及通过多种方式收集研究数据，包括通过使用连接医疗设备和可穿戴传感器。。

It can be used to run traditional, decentralised and hybrid trials, supports virtual consultations, remote patient monitoring, biological sample tracking and medicines delivery, and features a top-down view of ongoing trials for management, reporting and governance purposes.

它可用于运行传统，分散和混合试验，支持虚拟咨询，远程患者监测，生物样本跟踪和药物输送，并具有自上而下的管理，报告和治理目的正在进行的试验视图。

The suite is already being used by AZ to deliver clinical trials in 40 countries, and according to the company can reduce the time and cost of developing new medicines, bring care closer to home for patients and reduce the burden on health systems.

AZ已经在40个国家使用该套件进行临床试验，据该公司称，该套件可以减少开发新药的时间和成本，为患者提供更靠近家的护理，减轻卫生系统的负担。

Eventually, Evinova intends to branch out to develop its own digital remote patient monitoring and digital therapeutics (DTx) technologies, said AZ.

AZ说，最终，Evinova打算分支开发自己的数字远程患者监护和数字治疗（DTx）技术。

“The future of medicine development can be accelerated with digital solutions,” remarked Pascal Soriot, AZ’s chief executive. “We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale, provides a real opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions.”.

AZ首席执行官Pascal Soriot说：“数字解决方案可以加速医学发展的未来。“我们相信Evinova在大规模开发AI数字技术方面的科学专业知识和跟踪记录相结合，为从根本上改善患者护理，推动医疗转型和减少碳排放提供了真正的机会。”。

Cristina Durán, AZ’s chief digital health officer, R&D, and formerly a senior management consultant at Accenture, has been named president of Evinova, which is also working with Accenture and Amazon Web Services to deliver its platform.

AZ的首席数字卫生官CristinaDurán曾担任埃森哲的高级管理顾问，曾被任命为Evinova总裁，Evinova也与埃森哲和亚马逊网络服务公司合作提供平台。

She said the launch of the business will “help propel the [life sciences] sector forward in digital health, as we know healthcare professionals and regulators need digital solutions that work across pharma and support patients broadly.”

她表示，该业务的启动将“帮助推动[生命科学]领域在数字健康方面向前发展，因为我们知道医疗保健专业人员和监管机构需要数字解决方案，可以在制药领域开展工作并广泛支持患者。”

Duran was the lead author of a recently published paper in the journal Nature Medicine which found that the use of digital health technology in clinical trials can improve the patient experience with accelerated timelines and reduced costs.

杜兰是最近发表在“自然医学”杂志上的一篇论文的主要作者，该论文发现在临床试验中使用数字健康技术可以加快时间表并降低成本，改善患者体验。

“Coming from within the sector and with proven experience, Evinova will be uniquely placed to deliver science-based, evidence-led and human experience-driven solutions with the aim of improving patient experience and outcomes,” she said.

她说：“来自该部门内部并具有丰富的经验，Evinova将具有独特的地位，以提供基于科学，以证据为主导和以人类经验为驱动的解决方案，旨在改善患者的体验和结果。”。

Based on 2018 healthcare spend information, McKinsey estimates that digital health interventions alone have the potential to save the US healthcare system alone nearly $500 billion if fully adopted.

根据2018年医疗保健支出信息，麦肯锡估计，如果完全采用数字健康干预措施，仅凭美国医疗保健系统就有可能节省近500亿美元。